According to IMARC Group latest report titled “Albumin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, offers a comprehensive analysis of the industry, which comprises insights on albumin market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the global market. The global albumin market reached a value of US$ 5.4 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 7.7 Billion by 2027, exhibiting a CAGR of 6.15% during 2022-2027.

Albumin refers to a globular water-soluble protein present in blood plasma. It is organized in the liver and is critical for maintaining the blood volume and transporting hormones, enzymes, and bile salt molecules. Albumin is commonly available in bovine, human, and recombinant variants. It is essential for preventing leakage of fluids into the tissue and sustaining the intravascular colloid osmotic pressure (COP). Albumin is used as a blood volumizer for treating burns, liver disorders, rare diseases, blood loss trauma, and surgical complications. It is also utilized in pharmaceuticals for enhancing surface absorption, stabilization, and reducing aggregation and oxidation. As a result, albumin finds widespread applications in the manufacturing of drug delivery systems, therapeutics, culture media, and vaccines.

Request to Get the Free Sample Report: https://www.imarcgroup.com/albumin-market/requestsample

As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the purchase behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.

Market Trends:

The escalating prevalence of chronic medical ailments across the globe is among the primary factors driving the albumin market. Besides this, the elevating product requirement for treating acute respiratory distress syndrome, nephrosis, renal dialysis, hypovolemia, liver failure, cardiopulmonary disorders, hypoalbuminemia, etc., is further augmenting the market growth. Moreover, the increasing need for albumin to prevent the denaturation of active protein ingredients, thereby making it highly beneficial for the production of vaccines, is also catalyzing the global market. Apart from this, the growing popularity of human serum albumin (HSA) for replenishing proteins in human plasma and maintaining colloid oncotic pressure is acting as another significant growth-inducing factor. Furthermore, the extensive research and development (R&D) activities in biotechnology are expected to bolster the albumin market in the coming years. 

Explore Full Report with Table of Contents: https://www.imarcgroup.com/albumin-market

Competitive Landscape with Key players:

The report has also analysed the competitive landscape of the market with some of the key players being.

  • Albumedix Ltd
  • Biotest AG
  • Celgene Corporation (Bristol-Myers Squibb Company)
  • CSL Limited
  • Grifols SA
  • HiMedia Laboratories
  • Medxbio Pte Ltd
  • Merck KGaA
  • Octapharma AG
  • Takeda Pharmaceutical Company Limited
  • Thermo Fisher Scientific Inc.
  • Ventria Bioscience Inc

Albumin Market Segmentation:

Our report has categorized the market based on region, product, application and end use industry.

Breakup by Product:

  • Human Serum Albumin
  • Bovine Serum Albumin
  • Recombinant Albumin

Breakup by Application:

  • Therapeutics
  • Drug Formulation and Vaccine
  • Component of Media
  • Others

Breakup by End User:

  • Hospitals and Clinics
  • Pharmaceutical and Biotechnology Companies
  • Research Institutes

Breakup by Region:

  • North America (United States, Canada)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key highlights of the report:

  • Market Performance (2016-2021)
  • Market Outlook (2022-2027)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

We are updating our reports, If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Competitive landscape, etc. Click request free sample report, the report will be delivered to you in PDF format via email within 24 to 48 hours after the payment confirmation.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US:
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800